Partnership between Clearbrdige BioMedics and John Wayne Cancer Institute will initially focus on melanoma.
Hematology
Latest News
Advertisement
CME Content
Advertisement
Trisenox is the first approved acute leukemia treatment that is chemotherapy-free.
Top news of the week in oncology and cancer drug development.
Ninlaro regimen increased progression-free survival by 40% in patients with multiple myeloma.
Top news of the week in oncology and cancer drug development.
Top news of the week in oncology and cancer drug development.
Promising data on pediatric relapsed/refractory acute lymphoblastic leukemia to be presented.
Collaboration will examine potential opportunities for combining daratumumab and carfilzomib for the treatment of cancer.
CD98 molecule could be a potential therapeutic target in AML.
The companies plan to collaborate on clinical trials of a novel combination therapy for multiple myeloma.
Rituximab is a cancer medication that can be used in combination with methotrexate to treat symptoms of adult rheumatoid arthritis.
The FDA has accepted the biologics license application from Genentech for a subcutaneous formulation of rituximab for multiple blood cancer indications.
Top news of the week in oncology and cancer drug development.
Developed countries may be able to assist developing countries in ensuring their drugs are safe.
Xgeva targets the RANK ligand pathways to prevent the creation, function, and survival of osteoclasts.
Amgen announces top-line results from trial evaluating Xgeva in multiple myeloma.
Top news of the week in oncology and cancer drug development.
Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.
Top news of the week in oncology and cancer drug development.
Celgene and Agios will collaborate with a technology company to improve diagnostics for patients with acute myeloid leukemia.
Top news of the day from across the health care landscape.
Patients with memory dysfunctions or depression may be less likely maintain adherence to oral oncoltyics.
Top news of the week from The American Journal of Pharmacy Benefits.
Top news of the week in oncology, and cancer drug development.
Top news of the week in oncology, and cancer drug development.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
4
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
5